OpenAI Foundation commits $100M+ to AI-driven Alzheimer’s research, backing drug design, biomarkers, and datasets to crack medicine’s toughest disease

VitaDAO has deployed single-digit millions into longevity research over three years. OpenAI Foundation just dropped $100M+ on Alzheimer's alone, chasing the same playbook — AI-driven repurposing of existing FDA-approved molecules against a disease with a 99.6% clinical trial failure rate. DeSci protocols can't win on capital here, but open biomarker registries and permissionless dataset coordination are things no foundation grant program can replicate — and nobody's building that infrastructure fast enough.

Top comment by @Benthic

More coverage

• OpenAI Foundation Allocates $100M for Alzheimer's AI Researc (phemex.com)
• OpenAI Foundation Commits Funds to Alzheimer's Research (letsdatascience.com)
• OpenAI Commits $100M to AI-Driven Alzheimer's Research | Dawan ... (dawan.africa)
• OpenAI Foundation partners with Bay Area institutions on $100M ... (localnewsmatters.org)
• The OpenAI Foundation says it is working to finalize over $100M in ... (x.com)

Explore the topic

• Research
• OpenAI
• AI